News and Insights of 3D Printing and Manufacturing
HomeMedical
Ceramic tools show their potential where metal devices start to fail, with ceramics increasingly becoming the material of choice in many medical tools. Not only are they extremely heat and wear-resistant, they are also perfectly biocompatible and can be easily sterilized.
North Carolina-based medical 3D printing startup Phase has secured a $1.8 million grant from the National Institutes of Health (NIH) to advance its work in 3D printing technology for microfluidic organ-on-a-chip models.
Following the success of a breakthrough eye transplant, Belgian 3D printing company Materialise has introduced its latest solution to treat patients requiring total temporomandibular joint (TMJ) arthroplasty.
US-based 3D printer manufacturer 3D Systems has launched its new multi-material 3D printed denture offering. This is being advertised as the industry’s first solution for multi-material, jetted, and monolithic (one-piece) 3D printed dentures.
Desktop Health, the healthcare business unit of Massachusetts-based industrial 3D printer manufacturer Desktop Metal (DM) has announced a new formulation of its Flexcera resin for 3D printing gingiva.
Following its partnership with Airbus, metal AM company AddUp has collaborated with medical device startup Anatomic Implants to submit a 510(K) application for what the company claims to be the world’s first 3D printed toe joint replacement.
Austrian ceramic 3D printing company Lithoz will present the next development stage of its lithium disilicate material for dental 3D printing at LMT Lab Day Chicago 2024.
Chinese drug 3D printing firm Triastek has announced that its T22 3D printed gastric retention product has become the first drug of its kind to receive Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA).
UK-based robotics company Open Bionics has announced that its 3D printed finger device has been adopted for the first time by a hand amputee from London.
Edinburgh-based tumor 3D printing specialists Carcinotech has successfully raised £4.2 million in an investment round led by Eos Advisory (Eos) and the Investment Fund for Scotland (IFS).